Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage

Pharmacogenomics
Nuwan C HettigeVincenzo De Luca

Abstract

In order to administer antipsychotic medication with the most beneficial outcome, the appropriate drug and dose needs to be identified. Though often not considered in pharmacogenetic studies, dosage plays an important role in treatment outcome. This study set out to analyze the association between 109 SNPs and antipsychotic dosage among schizophrenia patients. In a previous study, we tested 134 SNPs in regards to antipsychotic dosage. In the current study, we tested additional markers in the same candidate genes that we investigated in the previous study to confirm our previous findings. We included 263 participants with schizophrenia spectrum disorders between the ages of 18-75. Each participant was assessed cross-sectionally to collect clinical and antipsychotic treatment information through a semi-structured interview. The antipsychotic dosage for each individual was standardized according to chlorpromazine equivalents (CPZe), defined daily dose, and the percentage of maximum dosage (PM%). For each participant, 109 SNPs from 29 candidate genes were imputed or genotyped using a Customized Illumina Chip. Polymorphisms in the GABRB1 gene were significantly associated with higher antipsychotic dosage according to CPZe and PM% st...Continue Reading

References

Jul 4, 1998·Brain Research. Brain Research Reviews·P SomogyiE H Buhl
Jul 25, 2000·Journal of Clinical Pharmacy and Therapeutics·N PoolsupT L Knight
Dec 10, 2003·Archives of General Psychiatry·Ofer AgidRobert B Zipursky
Apr 3, 2010·The American Journal of Psychiatry·David M GardnerRoss J Baldessarini
Jun 29, 2010·European Journal of Clinical Pharmacology·Guillermo GervasiniJuan Antonio Carrillo
Sep 10, 2011·Neural Plasticity·Guillermo Gonzalez-BurgosDavid A Lewis
Apr 24, 2012·Psychiatry Research·Eric Hermes, Robert Rosenheck
Jul 28, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia
Nov 7, 2012·Handbook of Experimental Pharmacology·Nathalie Ginovart, Shitij Kapur
Jul 23, 2013·Schizophrenia Research·Dana RavynHenry A Nasrallah
Jul 13, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Nuwan C HettigeVincenzo De Luca
Dec 9, 2014·Biological Psychiatry·Steven P Hamilton

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
Chip

Software Mentioned

PLINK
IMPUTE2

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here